LABOCANNA (Germany) Performance
| 9Y2 Stock | EUR 0.06 0.0002 0.31% |
On a scale of 0 to 100, LABOCANNA holds a performance score of 5. The firm owns a Beta (Systematic Risk) of -0.75, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning LABOCANNA are expected to decrease at a much lower rate. During the bear market, LABOCANNA is likely to outperform the market. Please check LABOCANNA's mean deviation, downside deviation, standard deviation, as well as the relationship between the semi deviation and coefficient of variation , to make a quick decision on whether LABOCANNA's current price history will revert.
Risk-Adjusted Performance
Modest
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in LABOCANNA SA ZY 10 are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, LABOCANNA reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Quick Ratio | 0.49 | |
| Fifty Two Week Low | 0.3280 | |
| Fifty Two Week High | 0.7680 |
LABOCANNA |
LABOCANNA Relative Risk vs. Return Landscape
If you would invest 5.70 in LABOCANNA SA ZY 10 on December 17, 2024 and sell it today you would earn a total of 0.68 from holding LABOCANNA SA ZY 10 or generate 11.93% return on investment over 90 days. LABOCANNA SA ZY 10 is currently producing 0.2616% returns and takes up 3.9565% volatility of returns over 90 trading days. Put another way, 35% of traded stocks are less volatile than LABOCANNA, and 95% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
LABOCANNA Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for LABOCANNA's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as LABOCANNA SA ZY 10, and traders can use it to determine the average amount a LABOCANNA's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0661
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 9Y2 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.96 actual daily | 35 65% of assets are more volatile |
Expected Return
| 0.26 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average LABOCANNA is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of LABOCANNA by adding it to a well-diversified portfolio.
LABOCANNA Fundamentals Growth
LABOCANNA Stock prices reflect investors' perceptions of the future prospects and financial health of LABOCANNA, and LABOCANNA fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on LABOCANNA Stock performance.
| Return On Equity | 82.13 | |||
| Return On Asset | 6.13 | |||
| Profit Margin | 119.42 % | |||
| Current Valuation | 5.16 M | |||
| Shares Outstanding | 7.65 M | |||
About LABOCANNA Performance
By analyzing LABOCANNA's fundamental ratios, stakeholders can gain valuable insights into LABOCANNA's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if LABOCANNA has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if LABOCANNA has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Labocanna S.A. provides solutions for call and contact center organizations in Poland. The company was formerly known as Foxbuy.com S.A. and changed its name to Labocanna S.A. in January 2021. CALL CENTER is traded on Frankfurt Stock Exchange in Germany.Things to note about LABOCANNA SA ZY performance evaluation
Checking the ongoing alerts about LABOCANNA for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for LABOCANNA SA ZY help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| LABOCANNA SA ZY has some characteristics of a very speculative penny stock | |
| LABOCANNA SA ZY had very high historical volatility over the last 90 days | |
| The company has a current ratio of 0.48, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist LABOCANNA until it has trouble settling it off, either with new capital or with free cash flow. So, LABOCANNA's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like LABOCANNA SA ZY sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for LABOCANNA to invest in growth at high rates of return. When we think about LABOCANNA's use of debt, we should always consider it together with cash and equity. |
- Analyzing LABOCANNA's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether LABOCANNA's stock is overvalued or undervalued compared to its peers.
- Examining LABOCANNA's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating LABOCANNA's management team can have a significant impact on its success or failure. Reviewing the track record and experience of LABOCANNA's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of LABOCANNA's stock. These opinions can provide insight into LABOCANNA's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for LABOCANNA Stock analysis
When running LABOCANNA's price analysis, check to measure LABOCANNA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LABOCANNA is operating at the current time. Most of LABOCANNA's value examination focuses on studying past and present price action to predict the probability of LABOCANNA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LABOCANNA's price. Additionally, you may evaluate how the addition of LABOCANNA to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |